Show simple item record

dc.contributor.authorGujral, DM
dc.contributor.authorShah, BN
dc.contributor.authorChahal, NS
dc.contributor.authorBhattacharyya, S
dc.contributor.authorSenior, R
dc.contributor.authorHarrington, KJ
dc.contributor.authorNutting, CM
dc.date.accessioned2017-04-11T09:24:09Z
dc.date.issued2015-09-01
dc.identifier.citationQJM : monthly journal of the Association of Physicians, 2016, 109 (6), pp. 383 - 389
dc.identifier.issn1460-2725
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/578
dc.identifier.eissn1460-2393
dc.identifier.doi10.1093/qjmed/hcv120
dc.description.abstractBACKGROUND: Primary radical radiotherapy (RT) for head and neck cancer (HNC) often results in significant radiation dose to the carotid arteries. AIM: We assessed whether HNC patients are at increased risk of a cerebrovascular event primarily due to RT or other risk factors for atherosclerosis by (i) risk-stratifying patients according to validated QRISK-2 and QSTROKE scores and (ii) comparing the prevalence of carotid artery stenosis (CAS) in irradiated and unirradiated carotid arteries. DESIGN: HNC patients treated with an RT dose >50 Gy to one side of the neck ≥2 years previously were included. METHODS: QRISK-2 (2014) and Q-STROKE (2014) scores were calculated. We compared the prevalence of CAS in segments of the common carotid artery on the irradiated and unirradiated sides of the neck. RESULTS: Fifty patients (median age of 58 years (interquartile range (IQR) 50-62)) were included. The median QRISK-2 score was 10% (IQR 4.4-15%) and the median QSTROKE score was 3.4% (IQR 1.4-5.3%). For both scores, no patient was classified as high risk. Thirty-eight patients (76%) had CAS in one or both arteries. There was a significant difference in the number of irradiated arteries with stenosis (N = 37) compared with unirradiated arteries (N = 16) (P < 0.0001). There were more plaques on the irradiated artery compared with the unirradiated side - 64/87 (73.6%) versus 23/87 (26.4%), respectively (P < 0.001).  CONCLUSIONS: Traditional vascular risk factors do not play a role in radiation-induced carotid atherosclerosis. Clinicians should be aware that traditional risk prediction models may under-estimate stroke risk in these patients.
dc.formatPrint-Electronic
dc.format.extent383 - 389
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectCarotid Arteries
dc.subjectHumans
dc.subjectHead and Neck Neoplasms
dc.subjectCarotid Artery Diseases
dc.subjectRadiation Injuries
dc.subjectUltrasonography
dc.subjectRadiotherapy Dosage
dc.subjectPrevalence
dc.subjectLogistic Models
dc.subjectRisk Assessment
dc.subjectRisk Factors
dc.subjectPredictive Value of Tests
dc.subjectMiddle Aged
dc.subjectFemale
dc.subjectMale
dc.subjectStroke
dc.titleDo traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients?
dc.typeJournal Article
rioxxterms.versionofrecord10.1093/qjmed/hcv120
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfQJM : monthly journal of the Association of Physicians
pubs.issue6
pubs.notes12 months
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume109
pubs.embargo.terms12 months
icr.researchteamTargeted Therapy
dc.contributor.icrauthorHarrington, Kevin


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record